Country: Israel
Language: English
Source: Ministry of Health
MARBOFLOXACIN
ELIEZER LINEVITZ LTD.
SOLUTION FOR INJECTION
MARBOFLOXACIN 160 MG/ML
I.M, I.V
Required
VETOQUINOL S.A., FRANCE
Therapeutic treatment of respiratory infections in cattle caused by sensitive strains of Pasteurella multocida and Manneimia haemolytica.In lactating cows: treatment of acute mastitis caused by sensitive strains of Escherichia coli
2019-04-30
1 CONSUMER LEAFLET FOR A VETERINARY PRODUCT This medicine is marketed according to a veterinarian’s prescription only. For animal use only 1. NAME OF THE VETERINARY MEDICINE, FORM AND STRENGTH Forcyl 160 mg/mL solution for injection for cattle veterinary 2. ACTIVE INGREDIENT and its quantity in a dose unit Marbofloxacin 160 mg/mL INACTIVE EXCIPIENTS: Each mL contains: Benzyl alcohol 15 mg For the full list of inactive excipients, see Section 13: " Additional information." 3. WHAT IS THE MEDICINE INTENDED FOR IN CATTLE: Therapeutic treatment of respiratory infections in cattle caused by sensitive strains of Pasteurella multocida and Mannheimia haemolytica. IN LACTATING COWS: Treatment of acute mastitis caused by strains of Escherichia coli sensitive to Marbofloxacin Therapeutic group: Fluoroquinolone 4. CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredient, to any other fluoroquinolones or to any of the product inactive excipients. Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). 5. SIDE EFFECTS In very rare cases (may occur in less than 1 of 10,000 treated animals), administration by the intramuscular route may cause transient local reactions such as pain and swelling at the injection site which may persist up to 7 days after injection. Fluoroquinolones are known to induce arthropathies. In cattle, such lesions were observed after a three days treatment with the 16% marbofloxacin 2 solution. These lesions did not induce clinical signs and should be reversible, particularly if they were to be observed after a single administration. In very rare cases (may occur in less than 1 of 10,000 treated animals), anaphylactic-type (allergic) reactions with a potentially fatal outcome might occur. Side effects can be reported to the Ministry of Health by clicking on the link "Adverse Drug Reactions Report" that appears on the home page of the Ministry of Health web site (www.health.gov.il), which leads to an online form for rep Read the complete document
Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Forcyl 160 mg/ml solution for injection for cattle veterinary 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE INGREDIENT(S): Marbofloxacin ....................... 160 mg EXCIPIENTS: Benzyl alcohol ………………... 15 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear yellow greenish to yellow brownish solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cattle: - Therapeutic treatment of respiratory infections caused by sensitive strains of _Pasteurella _ _multocida_ and _Mannheimia haemolytica_. In lactating cows: - Treatment of acute mastitis caused by_ _sensitive strains of _Escherichia coli._ 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to fluoroquinolones or to any of the excipients. Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS The efficacy of the product has not been tested on mastitis caused by Gram positive bacteria. Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when this product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Wherever possible, use of the product should only be based on susceptibility testing. Use of the product deviating from the instructions given in this SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINA Read the complete document